AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 71 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $50,000 | +100.0% | 60,472 | +450.7% | 0.00% | – |
| Q2 2018 | $25,000 | -28.6% | 10,980 | -9.1% | 0.00% | – |
| Q1 2018 | $35,000 | -30.0% | 12,085 | -32.7% | 0.00% | – |
| Q4 2017 | $50,000 | -3.8% | 17,963 | -48.3% | 0.00% | – |
| Q1 2014 | $52,000 | +116.7% | 34,761 | +197.5% | 0.00% | – |
| Q3 2013 | $24,000 | – | 11,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
| SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
| WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
| Caption Management, LLC | 748,200 | $503,000 | 0.02% |
| Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
| Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |